Role of HE4, CA72.4, and CA125 in monitoring ovarian cancer

HE4 in the Differential Diagnosis of a Pelvic Mass: A Case Report

(2011) Emanuela Anastasi et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The National Institute for Health and Clinical Excellence (NICE) guidelines for early detection of ovarian cancer: the pivotal role of the clinical laboratory

(2011) C. M. Sturgeon et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Potential Markers for Detection and Monitoring of Ovarian Cancer

(2011) Brandon J. D. Rein et al.   Journal of Oncology

Current clinical use of biomarkers for epithelial ovarian cancer

(2010) Richard G Moore et al.   CURRENT OPINION IN ONCOLOGY

Ovarian tumor marker HE4 is differently expressed during the phases of the menstrual cycle in healthy young women

(2010) Emanuela Anastasi et al.   TUMOR BIOLOGY

HE4: a new potential early biomarker for the recurrence of ovarian cancer

(2010) Emanuela Anastasi et al.   TUMOR BIOLOGY

CA-125 change after chemotherapy in prediction of treatment outcome among advanced mucinous and clear cell epithelial ovarian cancers

(2009) Chunqiao Tian et al.   CANCER

Predictive value of CA 125 and CA 72-4 in ovarian borderline tumors

(2009) Miriam S. Lenhard et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Accuracy of CA 125 in the diagnosis of ovarian tumors: A quantitative systematic review

(2008) Lidia Rosi Medeiros et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus

(2008) Richard G. Moore et al.   GYNECOLOGIC ONCOLOGY

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass

(2007) Richard G. Moore et al.   GYNECOLOGIC ONCOLOGY